Clinical Trials
3
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (100.0%)Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder
Phase 2
Withdrawn
- Conditions
- Post-Traumatic Stress DisordersPosttraumatic Stress DisordersStress Disorders, Post-TraumaticPost-Traumatic Stress Disorders, Combat-related
- Interventions
- First Posted Date
- 2015-03-10
- Last Posted Date
- 2016-04-18
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02384369
A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome
- First Posted Date
- 2014-08-15
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02217007
- Locations
- 🇺🇸
Rush University Medical Center, Chicago, Illinois, United States
🇺🇸North Shore University Hospital, Dept. of Psychiatry, Manhasset, New York, United States
A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia
- First Posted Date
- 2014-02-17
- Last Posted Date
- 2021-04-13
- Lead Sponsor
- Synchroneuron Inc.
- Registration Number
- NCT02064010
- Locations
- 🇺🇸
UCLA - Greater Los Angeles, Los Angeles, California, United States
News
No news found